New Rhein Healthcare Investors to sell stake in Softhale
New Rhein Healthcare Investors has agreed to sell its 60 percent stake in Softhale to Sino Biopharmaceutical Limited for an upfront payment of $110 million plus a profit share.
Nearly there!
A verification email is on its way to you. Please check your spam or junk folder just in case.
If you do not receive this within five minutes, please try to sign in again. If the problem persists, please email: subscriptions@pei.group .-
Sign in or Register
-
Issues with signing in? Click here
Don't have an account? Register now
-
